 |
N-acetylcysteinate Lysine |
|---|---|
| Trade Name | Nacystelyn Dry Powder Inhaler |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2000-12-27 00:00:00 |
| Sponsor | Galephar Pharmaceutical Research, Inc.;Road 198, No. 100 km. 14.7, Juncos Industrial Park;Juncos |
Related Access Program